|
?:reviewBody
|
-
Adding to the extant confusion swirling about the COVID-19 coronavirus disease pandemic in March 2020, the French government, including Health Minister Olivier Véran, issued warnings advising that infected persons should avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen: Dr. Amir Khan, a National Health Service (NHS) doctor and a senior university lecturer in the U.K., offered the following explanation about why taking anti-inflammatory drugs might have a deleterious effect on persons dealing with a COVID-19 infection: These warnings to avoid ibuprofen (commonly known by the brand name Advil) generated mixed reactions among the medical community, with some asserting that scientific evidence to support it was lacking, and others maintaining that it was generally good advice: Exemplifying that split of opinion, Dr. Tom Wingfield, senior clinical lecturer and honorary consultant physician at the Liverpool School of Tropical Medicine, observed that it was unclear whether the proffered advice about ibuprofen was specific to COVID-19 or merely ordinary good practice, but that in any case paracetamol (acetaminophen) would generally be preferred over ibuprofen to relieve symptoms caused by infection such as fever: As Khan cautioned, for now patients and their doctors will need to be aware of the careful balance between managing the symptoms of their long-term health condition and risking the devastating effects of the coronavirus. He advised that paracetamol or acetaminophen may be preferable alternative medications for pain and fever associated with COVID-19.
(en)
|
![[This page as RDF]](http://data.gesis.org/claimskg/static/rdf-icon.gif){kind=icon}